30mL multi-dose vial
Retatrutide targets three hormone receptors : GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Safety Boundaries and Handling Retatrutide supplied as a research peptide is not intended for human consumption, therapeutic use, diagnostic use, veterinary administration, or clinical application
Further increases to 1 mg or 2 mg weekly should only occur if tolerated and if additional glycaemic control is needed
Gentle and Versatile: Formulated to be suitable for all skin types, this soap is ideal for daily use by both men and women, making it a practical addition to any skincare regimen
REDEFINE 1 (Phase 3a, NEJM 2025) Garvey et al., n=3,417, 68 weeks